Further to the announcement by Psyence Group Inc. (Psyence Group) of the closing (Closing) of the business combination of its subsidiary, Psyence Biomedical Ltd. (PBM) with Newcourt Acquisition Corp. (Newcourt) (Business Combination or Spin-Out). Warwick-Corden Lloyd will step down as the Chief Financial Officer of Psyence Group to assume the position of Chief Financial Officer of PBM.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.329 USD | -7.53% |
|
-11.44% | -96.44% |
1st Jan change | Capi. | |
---|---|---|
-96.44% | 42.72L | |
+56.86% | 82TCr | |
+43.90% | 64TCr | |
-6.57% | 35TCr | |
+17.32% | 32TCr | |
+9.94% | 30TCr | |
+16.08% | 24TCr | |
+2.29% | 22TCr | |
+13.96% | 22TCr | |
+7.98% | 17TCr |
- Stock Market
- Equities
- PBM Stock
- News Psyence Biomedical Ltd.
- Psyence Biomedical Ltd. Appoints Warwick-Corden Lloyd as CFO